Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Biotricity Inc (NQ: BTCY ) 0.9500 -0.0400 (-4.04%) Streaming Delayed Price Updated: 4:00 PM EDT, Jun 21, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Press Releases about Biotricity Inc < Previous 1 2 3 4 Next > Biotricity Wins NIH Grant from the National Heart, Blood, and Lung Institute for AI-Enabled Real-Time Monitoring and Predictive Analytics for Stroke due to Chronic Kidney Failure September 07, 2022 Via ACCESSWIRE Biotricity Reports Financial Results for Fiscal 2023 First Quarter August 15, 2022 Via ACCESSWIRE Biotricity to Host Fiscal First Quarter 2023 Financial Results Conference Call on August 15th at 4:30 p.m. ET August 05, 2022 Via ACCESSWIRE Biotricity Reports Financial Results for Fiscal 2022 Fourth Quarter and Full Year July 14, 2022 Company Reports Record Revenue and Improved Margins From Biotricity, Inc. Via AccessWire Exposures COVID-19 Biotricity to Join Russell Microcap(R) Index June 23, 2022 REDWOOD CITY, CA / ACCESSWIRE / June 23, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced that the... From Biotricity, Inc. Via AccessWire Biotricity to Present at the 2022 H.C. Wainwright Global Investment Conference on Tuesday May 24th May 23, 2022 REDWOOD CITY, CA / ACCESSWIRE / May 23, 2022 / Biotricity Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, is scheduled to present... From Biotricity, Inc. Via AccessWire Biotricity Issues Shareholder Update May 05, 2022 Our newswire features a comprehensive, flat-fee Press Release service. Generate quality engagement with real-time analytics to improve visibility and expand your influence. From Biotricity, Inc. Via AccessWire Exposures COVID-19 Biotricity to Launch Commercial Sales of Its Disruptive Cardiac Monitoring Device, Biotres in April 2022 March 22, 2022 - Company reports pre-order sales from existing customers of its wireless wearable device for early detection of cardiac arrhythmias REDWOOD CITY, CA / ACCESSWIRE / March 22, 2022 / Biotricity, Inc.... From Biotricity, Inc. Via AccessWire Exposures Product Safety Biotricity Inc. (NASDAQ: BTCY) Featured in Virtual Coverage of the 34th Annual Roth Conference March 11, 2022 Via Investor Brand Network Biotricity Named to Fast Company's Annual List of the World's 50 Most Innovative Companies for 2022 March 08, 2022 Leader in early-detection cardiac diagnostics monitoring solutions joins the ranks of Canva, Microsoft, SpaceX, and more REDWOOD CITY, CA / ACCESSWIRE / March 8, 2022 / Biotricity, Inc. (NASDAQ:BTCY)... From Biotricity, Inc. Via AccessWire Biotricity, Inc. to Attend 34th Annual Roth Conference March 13th-15th March 04, 2022 - Follows fiscal third quarter earnings that saw revenue up 93% year-over-year and Company's highest-ever quarterly cash position - Biotricity now taking preorders for Biotres, an FDA-cleared,... From Biotricity, Inc. Via AccessWire Biotricity Now Taking Pre-Orders for its Biotres Wireless Wearable Cardiac Monitoring Device February 23, 2022 - Announcement follows FDA clearance - Pre-Orders begin on February 23, 2022 with units shipping April 1, 2022 REDWOOD CITY, CA / ACCESSWIRE / February 23, 2022 / Biotricity, Inc. (NASDAQ:BTCY)... From Biotricity, Inc. Via AccessWire Exposures Product Safety Biotricity Releases Fiscal 2022 Third Quarter Financial Results February 14, 2022 Management to host investor call on Tuesday February 15th at 4:15 pm ET - 93% YOY Revenue Gains to $1.93 Million - Revenue Outpaces SG&A Increase by 2.2x - Cash Position of $16.8 Million at Quarter End... From Biotricity, Inc. Via AccessWire Biotricity to Report Third Quarter Fiscal 2022 Financial Results on February 14, 2022 February 08, 2022 Management to host call on Tuesday, February 15th at 4:15pm ET Sees Calendar-2022 as a breakout year with commercial launch of Bioheart and FDA clearance for Biotres REDWOOD CITY, CA / ACCESSWIRE /... From Biotricity, Inc. Via AccessWire Exposures Product Safety Biotricity Receives FDA 510(k) Clearance for its Biotres Cardiac Monitoring Device January 24, 2022 Biotres is designed to continuously record ECG data for early detection of cardiac arrhythmias The Biotres addresses the $2 Billion-dollar holter market REDWOOD CITY, CA / ACCESSWIRE / January 24, 2022... From Biotricity, Inc. Via AccessWire Exposures Product Safety Biotricity Expands Distribution of New Bioheart Device on Amazon.com December 28, 2021 New Heart Monitoring Solution Delivers Personalized Heart Health Insights Directly to Your Smartphone Now Easy to Buy and Use: No Prescription Needed for Advanced Heart and Lifestyle Solution REDWOOD... From Biotricity, Inc. Via AccessWire Biotricity Completes $12 Million Non-Dilutive Debt Financing December 27, 2021 Capital infusion to finance inventory and annual recurring revenue subscriptions replaces expiring debt with more favorable terms 5-year term deal strengthens balance sheet, positions company for... From Biotricity, Inc. Via AccessWire Biotricity, a Leader in Remote Cardiac Health Monitoring Solutions, Issues Company Roadmap in 2021 Shareholder Letter December 07, 2021 The Company believes that it is "well-positioned for 2022." Letter highlights milestones, products roadmap, growth strategy and 2022 goals REDWOOD CITY, CA / ACCESSWIRE / December 7, 2021 / Biotricity,... From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Regulatory Biotricity Delivers Bioheart, A Groundbreaking Consumer Heart Monitor November 10, 2021 From Biotricity, Inc. Via Business Wire Biotricity Releases Fiscal 2022 Second Quarter Financial Results November 04, 2021 - Company reports tenth consecutive quarter of triple-digit year-over-year revenue growth - Strongest balance sheet since inception REDWOOD CITY, CA / ACCESSWIRE / November 4, 2021 / Biotricity Inc.... From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Product Safety Regulatory Biotricity to Report Second Quarter Fiscal 2022 Financial Results on November 4, 2021 November 02, 2021 Management to Host Conference Call and Live Webcast at 5pm ET REDWOOD CITY, CA / ACCESSWIRE / November 2, 2021 / Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology... From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Regulatory Biotricity to Discuss its Breakthrough Patient Monitoring Solutions at Virtual LD Micro Main Event XIV on Oct. 13th October 12, 2021 REDWOOD CITY, CA / ACCESSWIRE / October 12, 2021 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity" or the "Company"), a medical diagnostic and consumer healthcare technology company, today announced that... From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Regulatory Biotricity Launches Biocare Cardiac Application for Samsung's Galaxy Watch4 Series October 07, 2021 REDWOOD CITY, CA / ACCESSWIRE / October 7, 2021 / Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced the upcoming release of Biocare Cardiac... From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Product Safety Regulatory Remote Medical Diagnostic Company, Biotricity, to Ring the Nasdaq Stock Market Opening Bell on Thursday, October 7th October 06, 2021 Founder and CEO Waqaas Al Siddiq and Members of Biotricity Management Team to Attend Opening Bell Ceremony on Thursday, October 7, 2021 at 9:30am E.T. REDWOOD CITY, CA / ACCESSWIRE / October 6, 2021 /... From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Regulatory Biotricity to Discuss its 2022 Strategic Outlook and Product Pipeline, at Benzinga Healthcare Small Cap Conference on Sept. 30 September 28, 2021 REDWOOD CITY, CA / ACCESSWIRE / September 28, 2021 / Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today announced that its Chief Executive Officer... From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Regulatory Biotricity to Discuss Expansion of Remote Monitoring Medical Device Products at Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on September 22nd September 21, 2021 Biokit is the Expansion of the Company's Bioflux Cardiac-Diagnostic Offering Kits on Track for Launch in Early 2022 REDWOOD CITY, CA / ACCESSWIRE / September 21, 2021 / Biotricity Inc. (NASDAQ:BTCY), a... From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Regulatory Biotricity Unveils "Biokit" with 3 Personal Medical Devices to Expand into Cardiac Disease Management September 14, 2021 Company Expects New Personal Medical Device Kit to be available to customer by early 2022 REDWOOD CITY, CA / ACCESSWIRE / September 14, 2021 / Biotricity Inc. (NASDAQ:BTCY), a medical diagnostic and... From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Product Safety Regulatory Biotricity Announces Closing of Exercise of Underwriter's Option to Purchase Additional Common Stock September 13, 2021 Underwritten Public Offering of Common Stock Resulted in Total Gross Proceeds of $16 Million REDWOOD CITY, CA / ACCESSWIRE / September 13, 2021 / Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic... From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Regulatory Biotricity to Discuss Sales Expansion, Recent Financing, and Wearable Medical Device Portfolio Expansion at H.C. Wainwright Conference September 08, 2021 Company's Momentum Continuing with Sales Growth, Recent Nasdaq listing and Successful Equity Raise REDWOOD CITY, CA / ACCESSWIRE / September 8, 2021 / Biotricity, Inc. (NASDAQ:BTCY) ("Biotricity" or... From Biotricity, Inc. Via AccessWire Biotricity Completes Nasdaq Listing August 30, 2021 Closes $15 Million Underwritten Public Offering REDWOOD CITY, CA / ACCESSWIRE / August 30, 2021 / Biotricity, Inc. (NASDAQ:BTCY), a medical diagnostic and consumer healthcare technology company, today... From Biotricity, Inc. Via AccessWire Topics Regulatory Compliance Exposures Legal Regulatory < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.